Endomines has been approved for secondary listing on NASDAQ OMX Helsinki and publishes prospectus
NASDAQ OMX Helsinki has approved Endomines AB (publ) (“Endomines”) to be listed on the main list. Endomines filed the application on 2 May 2013 and the first day of trading in Endomines' share on NASDAQ OMX Helsinki is planned to be on 14 May 2013. Endomines shall maintain its primary listing on NASDAQ OMX Stockholm where the share will keep the same ticker as before, i.e. “ENDO”. On NASDAQ OMX Helsinki the short name will be “ENDOM”. The share will keep the same ISIN as before, i.e. SE0001803131. No new shares are issued in connection with the secondary listing. Those shareholders, who